PUROMYCIN AMINONUCLEOSIDE AND ADRIAMYCIN DISTURB CYTOSKELETAL AND EXTRACELLULAR-MATRIX PROTEIN ORGANIZATION, BUT NOT PROTEIN-SYNTHESIS OF CULTURED GLOMERULAR EPITHELIAL-CELLS
W. Coers et al., PUROMYCIN AMINONUCLEOSIDE AND ADRIAMYCIN DISTURB CYTOSKELETAL AND EXTRACELLULAR-MATRIX PROTEIN ORGANIZATION, BUT NOT PROTEIN-SYNTHESIS OF CULTURED GLOMERULAR EPITHELIAL-CELLS, Experimental nephrology, 2(1), 1994, pp. 40-50
Puromycin aminonucleoside (PA) and Adriamycin (ADR) cause glomerular p
roteinuria associated with degenerative alterations of glomenular visc
eral epithelial cells (GVEC) and detachment from the glomenular baseme
nt membrane when administered to rats. This in vitro study was perform
ed to define, in detail, the quantitative and qualitative changes of a
number of adhesion-associated proteins (cytoskeletal, extracellular m
atrix and integrin proteins) upon exposure to PA and ADR. By immunoflu
orescence we observed: (1) dose- and incubation-time-dependent filamen
t pattern changes and decreased staining of the cytoskeletal proteins
actin, vimentin, keratin, and beta-tubulin; (2) an altered distributio
n, and decreased expression of the extracellular matrix proteins lamin
in and heparan sulfate and (3) a loss of the beta(1)-integrin focal ad
hesions upon exposure to PA and ADR. Using an ELISA, a concentration-d
ependent decrease was found (a 50% reduction with 50 mu g/ml PA for 48
h and with 2 mu g/ml ADR for 24 h) in the production of cytoskeletal
and extracellular matrix proteins per cell. These general effects were
suggestive of a disturbance of protein synthesis but, by metabolic la
belling studies, no reduction in overall protein synthesis was found.
Using two-dimensional PAGE on S-35-methionine steady-state labeled cel
ls, no changes were found in intracellular protein patterns of PA- and
ADR-treated cells (pH 5-7.5, MW 110-20 kD). We hypothesize that expos
ure of GVEC in vitro to PA and ADR might result, directly or indirectl
y, in perturbation of the macromolecular organization of cytoskeletal
and extracellular matrix proteins with loss of GVEC adhesion.